Last reviewed 2026-06-01 · How we verify

Aminton (aminopicoline)

unknown active ✓ Verified Jun 2026

Aminton (generic name: aminopicoline) is a aminopicoline drug. It is currently in unknown development.

Aminton works by inhibiting the production of nitric oxide through the inhibition of inducible nitric oxide synthase.

Aminopicoline, also known as Aminton, is a small molecule drug class targeting inducible nitric oxide synthase. It is currently owned by an unknown entity, but its original development is not specified. The exact commercial status, indications, and pharmacokinetic properties of Aminton are unknown. As a result, its use and safety considerations cannot be fully evaluated. Further research is needed to determine its potential as a therapeutic agent.

At a glance

Generic name	aminopicoline
Drug class	aminopicoline
Target	Nitric oxide synthase, inducible
Therapeutic area	Hematology
Phase	unknown

Mechanism of action

Think of nitric oxide like a messenger in your body that helps blood vessels relax and widen. When inducible nitric oxide synthase is overactive, it can produce too much nitric oxide, leading to problems like inflammation and tissue damage. Aminton helps by blocking this enzyme, reducing the amount of nitric oxide produced and potentially alleviating these issues.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Aminton CI brief — competitive landscape report
Aminton updates RSS · CI watch RSS
portfolio CI

Frequently asked questions about Aminton

What is Aminton?

Aminton (aminopicoline) is a aminopicoline drug.

How does Aminton work?

Aminton works by inhibiting the production of nitric oxide through the inhibition of inducible nitric oxide synthase.

What is the generic name of Aminton?

aminopicoline is the generic (nonproprietary) name of Aminton.

What drug class is Aminton in?

Aminton belongs to the aminopicoline class. See all aminopicoline drugs at /class/aminopicoline.

What development phase is Aminton in?

Aminton is in unknown.

What does Aminton target?

Aminton targets Nitric oxide synthase, inducible and is a aminopicoline.

Drug class: All aminopicoline drugs
Target: All drugs targeting Nitric oxide synthase, inducible
Manufacturer: — full pipeline
Therapeutic area: All drugs in Hematology

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing